Yosuke Shimazu

422 total citations
21 papers, 237 citations indexed

About

Yosuke Shimazu is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Yosuke Shimazu has authored 21 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Yosuke Shimazu's work include Glioma Diagnosis and Treatment (8 papers), interferon and immune responses (4 papers) and Virus-based gene therapy research (4 papers). Yosuke Shimazu is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), interferon and immune responses (4 papers) and Virus-based gene therapy research (4 papers). Yosuke Shimazu collaborates with scholars based in Japan and United States. Yosuke Shimazu's co-authors include Isao Date, Kazuhiko Kurozumi, Kentaro Fujii, Joji Ishida, Tomotsugu Ichikawa, Manabu Onishi, Yoshihiro Otani, Tetsuo Oka, E. Antonio Chiocca and Yusuke Tomita and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of neurosurgery.

In The Last Decade

Yosuke Shimazu

19 papers receiving 235 citations

Peers

Yosuke Shimazu

GENET

ONCOL

IMMUN

GENET

Marko Ständer Germany

Nathalie Nadal France

Brock Armstrong United States

Alison Roos United States

Noriyuki Kijima Japan

Julie Sesen United States

Montse Puigdelloses Spain

Naomi Tsuchida Japan

Laure Malric France

Marko Ständer Germany

Yosuke Shimazu

190 ×1.4

85 ×1.0

GENET

76 ×1.5

ONCOL

47 ×0.9

IMMUN

23 ×0.6

GENET

Citations per year, relative to Yosuke Shimazu Yosuke Shimazu (= 1×) peers Marko Ständer

Countries citing papers authored by Yosuke Shimazu

Since Specialization

Citations

This map shows the geographic impact of Yosuke Shimazu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosuke Shimazu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosuke Shimazu more than expected).

Fields of papers citing papers by Yosuke Shimazu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosuke Shimazu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosuke Shimazu. The network helps show where Yosuke Shimazu may publish in the future.

Co-authorship network of co-authors of Yosuke Shimazu

This figure shows the co-authorship network connecting the top 25 collaborators of Yosuke Shimazu. A scholar is included among the top collaborators of Yosuke Shimazu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosuke Shimazu. Yosuke Shimazu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tamura, Yosuke, Yosuke Shimazu, Masahiro Arai, et al.. (2024). Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer. Anticancer Research. 44(12). 5531–5539.

Otani, Yoshihiro, Kentaro Fujii, Joji Ishida, et al.. (2024). Comparative analysis of intraoperative MRI and early postoperative MRI findings in glioma surgery patients. Journal of neurosurgery. 142(5). 1–9. 2 indexed citations

Tomita, Yusuke, Yosuke Shimazu, Agila Somasundaram, et al.. (2022). A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell‐of‐origin dependent effects of H3K27M. Glia. 70(9). 1681–1698. 18 indexed citations

Kurozumi, Kazuhiko, Yoshihiro Otani, Atsuhito Uneda, et al.. (2022). Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis. PLoS ONE. 17(8). e0273242–e0273242. 3 indexed citations

Uneda, Atsuhito, Kazuhiko Kurozumi, Atsushi Fujimura, et al.. (2021). Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration. Acta Neuropathologica Communications. 9(1). 29–29. 33 indexed citations

Hiramatsu, Masafumi, Kenji Sugiu, Tomohito Hishikawa, et al.. (2020). Detailed Arterial Anatomy and Its Anastomoses of the Sphenoid Ridge and Olfactory Groove Meningiomas with Special Reference to the Recurrent Branches from the Ophthalmic Artery. American Journal of Neuroradiology. 41(11). 2082–2087. 8 indexed citations

Tomita, Yusuke, Kazuhiko Kurozumi, Kentaro Fujii, Yosuke Shimazu, & Isao Date. (2020). Neurosurgery for brain metastasis from breast cancer. Translational Cancer Research. 9(8). 5063–5076. 4 indexed citations

Kurozumi, Kazuhiko, Kentaro Fujii, Yosuke Shimazu, et al.. (2020). Study Protocol of a Phase I/IIa Clinical Trial of Ad-SGE-REIC for Treatment of Recurrent Malignant Glioma. Future Oncology. 16(6). 151–159. 9 indexed citations

Muraoka, Kenichiro, et al.. (2017). Effectiveness of Antiplatelet Drug Loading before Acute-phase Coil Embolization of Ruptured Cerebral Aneurysms. Journal of Neuroendovascular Therapy. 12(2). 75–80. 2 indexed citations

10.

Okuma, Yu, et al.. (2017). A Case of Postoperative Transverse Sinus Dural Arteriovenous Fistula Treated with Selective Sinus Packing: Usefulness of Quadriaxial Catheter System. Journal of Neuroendovascular Therapy. 11(8). 425–430. 2 indexed citations

11.

Oka, Tetsuo, Kazuhiko Kurozumi, Yosuke Shimazu, et al.. (2016). A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy. Scientific Reports. 6(1). 33319–33319. 14 indexed citations

12.

Murai, Satoshi, Tomotsugu Ichikawa, Kazuhiko Kurozumi, et al.. (2016). Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers. Journal of Clinical Neuroscience. 33. 148–153. 6 indexed citations

13.

Ishida, Joji, Kazuhiko Kurozumi, Tomotsugu Ichikawa, et al.. (2015). Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma. Brain Tumor Pathology. 32(4). 245–252. 11 indexed citations

14.

Onishi, Manabu, Tomotsugu Ichikawa, Kazuhiko Kurozumi, et al.. (2015). Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma. Brain Tumor Pathology. 32(3). 184–194. 28 indexed citations

15.

Shimazu, Yosuke, Kazuhiko Kurozumi, Tomotsugu Ichikawa, et al.. (2014). Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma. Gene Therapy. 22(2). 146–154. 23 indexed citations

16.

Ishida, Joji, Manabu Onishi, Kazuhiko Kurozumi, et al.. (2014). Integrin Inhibitor Suppresses Bevacizumab-Induced Glioma Invasion. Translational Oncology. 7(2). 292–302.e1. 34 indexed citations

17.

Fujii, Kentaro, Kazuhiko Kurozumi, Tomotsugu Ichikawa, et al.. (2013). The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus. Cancer Gene Therapy. 20(8). 437–444. 23 indexed citations

18.

Onishi, Manabu, Kazuhiko Kurozumi, Tomotsugu Ichikawa, et al.. (2013). Gene expression profiling of the anti-glioma effect of Cilengitide. SpringerPlus. 2(1). 160–160. 12 indexed citations

19.

Haruma, Jun, Kenji Sugiu, Yosuke Shimazu, et al.. (2013). [Surgical and endovascular treatment for superior cerebellar artery aneurysms: report of two cases].. PubMed. 41(1). 45–51. 2 indexed citations

20.

Sasaki, Kuniaki, et al.. (1992). Anal Canal Cancer Detected During the Treatment of Perineal Abscess; A Case Report.. Nihon Daicho Komonbyo Gakkai Zasshi. 45(7). 1004–1007. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact